Rex C. Bentley

Rex C. Bentley

Auto-generated profile, based on publicly available information

Rex C. Bentley

Department of Pathology, Duke University School of Medicine, Durham, North Carolina

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 1990 in Clinical Immunology and Immunopathology
Verified
Journal Article
Closed access
ECE.William St. Clair
E.William St. Clair
CQCharles C. Query
Charles C. Query
RBRex Bentley
Rex Bentley
JKJack D. Keene
Jack D. Keene
RPRichard P. Polisson
Richard P. Polisson
DPDavid S. Pisetsky
David S. Pisetsky

1 October 2013 in Reproductive Sciences
Verified
Journal Article
Closed access
BCBernard J. Canzoneri
Bernard J. Canzoneri
Liping FengLiping Feng
Liping Feng
CGChad A. Grotegut
Chad A. Grotegut
RBRex C. Bentley
Rex C. Bentley
RHR. Phillips Heine
R. Phillips Heine
AMAmy P. Murtha
Amy P. Murtha

3 September 2020 in American Journal of Clinical Pathology
Verified
Journal Article
Closed access
CUCaroline I M Underwood
Caroline I M Underwood
DCDiana M Cardona
Diana M Cardona
RBRex C Bentley
Rex C Bentley
GSGuomiao Shen
Guomiao Shen
XFXiaojun Feng
Xiaojun Feng
Rami N. Al-RohilRami N. Al-Rohil
Rami N. Al-Rohil
Objectives: Soft tissue sarcomas are a group of tumors derived from the mesenchymal origin. Historically, they have been classified according to morphologic and immunohistochemical characteristics. The advent of multiplexed next-generation sequencing (NGS), specifically RNA sequencing, has modified the classification of such tumors and others by determining categorization based on molecular alterations. The NUTM1 rearrangement, previously thought to be present only in carcinomas, has recently been reported in poorly differentiated high-grade sarcomas of the soft tissue. We present the first reported case of an epithelioid hyalinizing sarcoma harboring the MGA-NUTM1 fusion in an acral site.Methods: Histopathologic, immunohistochemical, and molecular testing were performed on resection tissue.Results: Histologically, the tumor showed an epithelioid morphology with prominent background hyalinization. Immunohistochemically, the tumor expressed CD99 and nuclear NUT-1. By NGS the tumor harbors MGA-NUTM1 fusion.Conclusions: Our findings support more extensive use of NGS for accurate sarcoma classification and identification of potential therapeutic targets. Furthermore, they corroborate the fact that NUTM1-rearranged soft tissue tumors represent a spectrum of heterogeneous morphologic entities. This case also highlights the utility of NUT-1 immunohistochemical study as a possible screening tool for NUTM1-fused sarcomas.

1 November 2020 in Clinical Lung Cancer
Verified
Journal Article
Closed access
ESErica Shen
Erica Shen
JXJoanne Xiu
Joanne Xiu
RBRex Bentley
Rex Bentley
GLGiselle Y. López
Giselle Y. López
KWKyle M. Walsh
Kyle M. Walsh

2 June 2022 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Closed access
PDF file
ABAlexandra Bukowski
Alexandra Bukowski
CHCathrine Hoyo
Cathrine Hoyo
MHMichael G. Hudgens
Michael G. Hudgens
WBWendy R. Brewster
Wendy R. Brewster
FVFidel Valea
Fidel Valea
JSJennifer S. Smith
Jennifer S. Smith
Background: High-risk human papillomavirus (hrHPV) testing is utilized in primary cervical cancer screening, generally along with cytology, to triage abnormalities to colposcopy. Most screening-based hrHPV testing involves pooled detection of any hrHPV or of HPV16/18. Cervical neoplasia progression risks based on extended hrHPV genotyping—particularly non-16/18 hrHPV types—are not well characterized. HPV genotype-specific incidence of high-grade cervical intraepithelial neoplasia or more severe (CIN2+) following an abnormal screening result was examined. Methods: We assessed a US-based prospective, multiracial, clinical cohort of 343 colposcopy patients with normal histology (n = 226) or CIN1 (n = 117). Baseline cervical samples underwent HPV DNA genotyping, and participants were followed up to 5 years. Genotype-specific CIN2+ incidence rates (IR) were estimated with accelerated failure time models. Five-year CIN2+ risks were estimated nonparametrically for hierarchical hrHPV risk groups (HPV16; else HPV18/45; else HPV31/33/35/52/58; else HPV39/51/56/59/68). Results: At enrollment, median participant age was 30.1 years; most (63%) were hrHPV-positive. Over follow-up, 24 participants progressed to CIN2+ (7.0%). CIN2+ IR among hrHPV-positive participants was 3.4/1,000 person-months. CIN2+ IRs were highest for HPV16 (8.3), HPV33 (7.8), and HPV58 (4.9). Five-year CIN2+ risk was higher for HPV16 (0.34) compared with HPV18/45 (0.12), HPV31/33/35/52/58 (0.12), and HPV39/51/56/59/68 (0.16) (P = 0.05). Conclusions: Non-16/18 hrHPV types are associated with differential CIN2+ progression rates. HPV16, 33, and 58 exhibited the highest rates over 5 years. HPV risk groups warrant further investigation in diverse US populations. Impact: These novel data assessing extended HPV genotyping in a diverse clinical cohort can inform future directions to improve screening practices in the general population.

1 February 1999
Verified
Journal Article
Closed access
LLLester J Layfield
Lester J Layfield
RBR C Bentley
R C Bentley
JMJ M Mirra
J M Mirra
Marked nuclear atypia can be found in a variety of benign mesenchymal tumors, including ancient schwannomas, symplastic leiomyomas, osteoblastomas, and chondromyxoid fibromas. Such nuclear atypia is believed to represent a degenerative phenomenon and does not indicate aggressive behavior. Separation of these pleomorphic but benign lesions from true sarcomas may be difficult. We are aware of only one prior description of such degenerative atypia in benign giant cell tumor of bone. We report a benign giant cell tumor of bone arising in the sacrum of a 21-year-old white female. Preoperative embolization of this lesion had been performed, and subsequent curetting revealed marked atypia suggestive of an anaplastic malignancy. However, only very rare mitotic figures were present, and the radiographs were consistent with a benign giant cell tumor. A diagnosis of benign giant cell tumor was made, and no recurrence or metastases have been observed during the 4-year postoperative period.